• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

Asean Breaking News

Update latest Asean news

  • About Us
  • Privacy Policy
  • Disclaimers
  • DMCA
  • Contact Us
  • Submit your story

You are here: Home / Archives for Generic for advair

Generic for advair

Mylan launches Advair generic at one-third price

February 12, 2019 channelnewsasia Leave a Comment

REUTERS: Mylan NV on Tuesday priced its generic version of GlaxoSmithKline's blockbuster asthma treatment Advair 70 percent lower than the branded medicine.The treatment, the first generic of Advair, is approved in three doses and will be priced between US$93.71 and US$153.14, the company said.Advair targets certain patients with asthma or chronic obstructive pulmonary disease and brought in revenue of about US$4.19 billion in 2017 for the London-listed GSK.Mylan received approval for the treatment from the U.S. Food and Drug Administration last month.In the United States, more than 26 million people are known to have asthma, of which about seven million are children.The FDA has declined to approve several Advair copycats including those from Novartis AG and Hikma Pharmaceuticals.Mylan's shares gained 1.4 percent at US$31.46 in morning trade.(Reporting by Aakash Jagadeesh Babu in Bengaluru; Editing by Sriraj Kalluvila) … [Read more...] about Mylan launches Advair generic at one-third price

Health zoloft generic price, metronidazole generic price, generic prices, advair retail price, advair discount prices, advair diskus price comparison, advair diskus price walmart, advair diskus price, advair diskus price walgreens, advair diskus price without insurance, keswick launch prices, mylan price, mylan generics, launch price of iphone 5 in india, launching price, Mylan Generic, the generics pharmacy price list, ps2 price at launch, launch price of xbox one, launch trampoline park prices, mylan generic drugs, generic advair, price advair diskus 250 50, generic for advair, ezetimibe generic price, price advair, GlaxoSmithKline, Advair, Mylan, medical health, Mylan NV, generic


Drugmaker GlaxoSmithKline’s profit boosted by Trump’s reforms

February 7, 2019 channelnewsasia Leave a Comment

LONDON: Pharmaceutical giant GlaxoSmithKline on Wednesday (Feb 6) said group annual net profit more than doubled in 2018, largely on lower R&D and US tax costs.Profit after tax soared to £3.62 billion (US$4.69 billion) last year compared with £1.53 billion in 2017 as the multinational paid less tax under US President Donald Trump's reforms.GSK also slashed research and development (R&D) costs in 2018, its earnings statement revealed.Annual revenue grew two percent to £30.82 billion."GSK delivered improved operating performance in 2018 with group sales growth, strong commercial execution of new product launches, especially (shingles vaccine) Shingrix, continued cost discipline and better cash generation," said chief executive Emma Walmsley.GSK said it expected earnings per share to fall by up to nine per cent this year, "reflecting recent approval of a generic competitor" in the United States to its blockbuster asthma drug Advair.Following the results, GSK's … [Read more...] about Drugmaker GlaxoSmithKline’s profit boosted by Trump’s reforms

Business profit boost login, unibet profit boost, profit boost, Trump Tax Reform Plan, boost profits, trump and immigration reform, trumps tax reform, trump tax reform, healthcare reform trump, immigration reform trump, trump immigration reform, Pharmaceutical, GlaxoSmithKline, lower R&D, US tax cost

FDA approves Mylan’s generic of Advair asthma treatment

January 31, 2019 channelnewsasia Leave a Comment

REUTERS: The U.S. Food and Drug Administration (FDA) approved Mylan NV's generic version of GlaxoSmithKline-developed blockbuster asthma treatment Advair, driving shares of Mylan 7 percent higher on Wednesday.Mylan received approval to market its generic inhaler in three dosages for the twice-daily treatment of asthma in patients aged four years and older, the FDA said.The FDA has declined to approve several Advair knock-offs in the past from drugmakers including Novartis AG, Hikma Pharmaceuticals and Mylan itself, whose generic was rejected last year.In the United States, more than 26 million people are known to have asthma, and about seven million of these people are children, the FDA said.British-listed GSK reported revenue of about US$4.19 billion from Advair in 2017.Even though the potential revenue opportunity from a generic version of Advair has fallen over the past several years, Wednesday's approval is nonetheless important to Mylan, Citi analyst Liav Abraham said.Analysts at … [Read more...] about FDA approves Mylan’s generic of Advair asthma treatment

Health fda approves new diabetes treatment, fda approved menopause treatment, generic advair, Mylan Generic, mylan generic drugs, mylan generic viagra, mylan generics, FDA approved contraceptives, Get FDA Approval, what requires fda approval, accelerated approval fda, treatment works approval, fda approved drugs 2015, generic approvals, fda approved drugs 2017, how long does fda approval take, FDA Drug Approval, fda approval calendar, newly fda approved drugs, amarin fda approval, fda approves new ms drug, a treatment for asthma, neutrophilic asthma treatment, inhalation treatment asthma, athletic asthma treatment, best treatment for cough variant asthma, tcm treatment for asthma, allergy induced asthma treatment, treatment for allergy induced asthma, FDA, Advair, Mylan, medical health, Mylan NV, generic

Experts query case for GlaxoSmithKline’s new 3-in-1 lung drug

April 19, 2018 channelnewsasia Leave a Comment

Health Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline, which the company hopes will help it keep its lead in respiratory medicine despite rising competition. 19 Apr 2018 05:05AM Bookmark LONDON: Two medical experts have urged caution in using a new three-in-one inhaler for chronic lung disease from GlaxoSmithKline, which the company hopes will help it keep its lead in respiratory medicine despite rising competition.Trelegy Ellipta was licensed for use last year and full results from a positive clinical trial were published on Wednesday in the New England Journal of Medicine (NEJM). A critical accompanying editorial, however, may make some doctors think twice before writing prescriptions.Trelegy is the first once-daily triple medicine for chronic obstructive pulmonary disease (COPD), putting GSK ahead of rivals such as AstraZeneca and Novartis, and it showed benefits over other treatments in the … [Read more...] about Experts query case for GlaxoSmithKline’s new 3-in-1 lung drug

Health new anti tb drugs, new bone building drug, new cancer killing drug, gilead new hep c drug, new breast cancer drug, new anti inflammatory drugs, new breast cancer drugs, new fda approved drugs, fda approves new weight loss drug, fda approves new breast cancer drug, case query in sql, case in sql query, case new holland india, Invest New Drugs, new drug flocka, kelo v. city of new london case brief, drug recognition expert, drug related cases, New Case Holland, fda approves new ms drug, new non small cell lung cancer treatments, new treatment for lung cancer, astrazeneca lung cancer drug, immunotherapy lung cancer drugs, new treatments for lung cancer stage 4, investigational new drug database, compassionate investigational new drug program, chemotherapy drugs for lung cancer

Primary Sidebar

Categories

Asia Backstage Bacolod Basketball Breaking News Business Business News Canada Career Cebu Davao Entertainment Featured Columns Finance GTA Headlines Health Inside News Instagram Life Lifestyle Litra-Talk Bansa Probinsiya Metro Opinyon Palaro Showbiz True Confessions Dr. Love Kutob Komiks local Luzon Manila Metro Mindanao National News Opinion Opinions and Editorials Other Sports Overseas Provincial Queen's Park Singapore sport Sports Tech Insider Technology Today's Headline Photos Travel Uncategorized Weekly World

Recent Posts

  • News Macron, Putin weigh ‘deteriorated’ situation in Syria
  • News Karl Marx memorial vandalized in London for second time
  • News Thousands mark 3 months of France’s ‘yellow vest’ protests
  • News Saudi defends app allowing men to monitor women relatives
  • News UK airline flybmi collapses under fuel costs, Brexit pressures
  • News UK’s May to speak to every EU leader in bid to break Brexit deadlock
  • News LeBron says owning NBA club ‘would have to be right fit’
  • Di Grassi seizes Mexico Formula E win at the line
  • News Babaeng ‘tulak’ arestado sa QC
  • News Nasa 30 pamilya, nawalan ng bahay sa sunog sa Maynila

Copyright © 2019 Asean Breaking News. Power by Wordpress.